Indoco Remedies Faces FDA Hurdle, But AnaCipher Shines with Flawless Inspection

Indoco Remedies' facility in Goa obtained a Form 483 with nine observations after receiving a USFDA inspection, although the company clarified that supplies and revenues would remain unaffected. While this was occurring, Indoco's clinical research organization, AnaCipher, came out unscathed from a USFDA inspection with zero observations. AnaCipher has had its seventh consecutive inspection without any Form 483s, which only shows that the company has good compliance standards consistently across its premises.

 

CNBC-TV18, Business Standard, Medical Dialogues